Role of miRNAs in T‐cell activation and Th17/Treg‐cell imbalance in acquired aplastic anemia

G. Sabreen,Khaliqur Rahman,Ruchi Gupta,Chandra P. Chaturvedi,Jyotika Srivastava,Dinesh Chandra,Manish K. Singh,S. Yadav,Akhilesh Sharma,Manoj Sarkar,Rajesh Kashyap
DOI: https://doi.org/10.1111/ijlh.14243
2024-02-17
International Journal of Laboratory Hematology
Abstract:Background Altered T‐cell repertoire with an aberrant T‐cell activation and imbalance of the Th17/Treg cells has been reported in acquired aplastic anemia (aAA). miRNAs are well known to orchestrate T‐cell activation and differentiation, however, their role in aAA is poorly characterized. The study aimed at identifying the profile of miRNAs likely to be involved in T‐cell activation and the Th17/Treg‐cell imbalance in aAA, to explore newer therapeutic targets. Methods Five milliliters peripheral blood samples from 30 patients of aAA and 15 healthy controls were subjected to flow cytometry for evaluating Th17‐ and Treg‐cell subsets. The differential expression of 7 selected miRNAs viz; hsa‐miR‐126‐3p, miR‐146b‐5p, miR‐155‐5p, miR‐16, miR‐17, miR‐326, and miR‐181c was evaluated in the PB‐MNCs. Expression analysis of the miRNAs was performed using qRT‐PCR and fold change was calculated by 2−ΔΔCt method. The alterations in the target genes of deregulated miRNAs were assessed by qRT‐PCR. The targets studied included various transcription factors, cytokines, and downstream proteins. Results The absolute CD3+ lymphocytes were significantly elevated in the PB of aAA patients when compared with healthy controls (p
hematology
What problem does this paper attempt to address?